As of 2024-09-19, the Relative Valuation of Neogenomics Inc (NEO) is (19.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.16 USD, the upside of Neogenomics Inc based on Relative Valuation is -223.2%.
The range of the Relative Valuation is (19.75) - (20.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.2x - 34.9x | 33.1x |
| Forward P/E multiples | 29.5x - 33.7x | 31.9x |
| Fair Price | (19.75) - (20.65) | (19.91) |
| Upside | -222.2% - -227.8% | -223.2% |
| Date | P/E |
| 2024-09-18 | -26.37 |
| 2024-09-17 | -26.59 |
| 2024-09-16 | -26.65 |
| 2024-09-13 | -26.76 |
| 2024-09-12 | -26.44 |
| 2024-09-11 | -26.62 |
| 2024-09-10 | -25.49 |
| 2024-09-09 | -24.71 |
| 2024-09-06 | -26.18 |
| 2024-09-05 | -26.45 |
| 2024-09-04 | -25.64 |
| 2024-09-03 | -25.90 |
| 2024-08-30 | -26.96 |
| 2024-08-29 | -26.80 |
| 2024-08-28 | -26.65 |
| 2024-08-27 | -26.75 |
| 2024-08-26 | -26.73 |
| 2024-08-23 | -27.19 |
| 2024-08-22 | -26.44 |
| 2024-08-21 | -26.81 |
| 2024-08-20 | -26.57 |
| 2024-08-19 | -27.34 |
| 2024-08-16 | -26.41 |
| 2024-08-15 | -26.31 |
| 2024-08-14 | -25.82 |
| 2024-08-13 | -26.90 |
| 2024-08-12 | -26.00 |
| 2024-08-09 | -27.01 |
| 2024-08-08 | -27.61 |
| 2024-08-07 | -25.87 |
| 2024-08-06 | -26.37 |
| 2024-08-05 | -26.45 |
| 2024-08-02 | -28.02 |
| 2024-08-01 | -28.56 |
| 2024-07-31 | -28.94 |
| 2024-07-30 | -28.18 |
| 2024-07-29 | -23.89 |
| 2024-07-26 | -24.28 |
| 2024-07-25 | -24.61 |
| 2024-07-24 | -24.77 |
| 2024-07-23 | -24.37 |
| 2024-07-22 | -24.15 |
| 2024-07-19 | -23.68 |
| 2024-07-18 | -24.06 |
| 2024-07-17 | -25.30 |
| 2024-07-16 | -25.85 |
| 2024-07-15 | -24.20 |
| 2024-07-12 | -24.14 |
| 2024-07-11 | -23.42 |
| 2024-07-10 | -22.06 |